品牌资讯网欢迎您~!

设为首页

当前位置:首页>文传商讯列表

Galderma to Present Extensive New Clinical Data Across Its Portfolio of Neuromodulators, Fillers and Biostimulators at the IMCAS World Congress 2022

时间:2022年06月03日 07:14:48

Strong clinical data supporting Alluzience (abobotulinumtoxinA, ABO), the first liquid, ready-to-use neuromodulator as an effective and well-tolerated treatment for glabellar (frown) lines, with a rapid onset and long duration of action of up to six months
Data confirming that Dysport was consistently efficacious for the treatment of frown lines, was well tolerated and had a fast onset of effect across three trials with high patient satisfaction reported up to 6 months after injection in phase III trials
Phase IV data confirming the effectiveness and natural-looking effects with the Restylane range of hyaluronic acid fillers, with all patients achieving the aim of their treatment, whether it was projection or contouring/volumization with results that were natural-looking with high subject satisfaction
Presentation of the latest extension study for Sculptra, the original poly-L-lactic acid (PLLA) which demonstrated it to be well-tolerated and with long-lasting effectiveness until week 96 using reconstituted 8mL dilution.

ZUG, Switzerland--(BUSINESS WIRE)--Galderma will present a range of new clinical data and analyses across its portfolio during nine poster sessions and two symposia at the upcoming International Master Course on Aging Science (IMCAS) World Congress 2022 in Paris from June 3-5, 2022.

“At Galderma, we are committed to advancing dermatology for every skin story. The extensive series of oral and poster presentations with new data from across our portfolio demonstrates our drive for innovation across the industry. We will also be hosting two symposia with leading physicians, reinforcing our partnership with the aesthetics community as we present work completed with them to deliver holistic individualized treatments (HITs) for patients and the science and clinical experience behind our latest innovation Alluzience, the first ready-to-use neuromodulator”

Flemming Ørnskov, M.D., MPH

Chief Executive Officer

Galderma

 
来源:  作者:
相关新闻
本网网友:☆我还会想你
评论:做女孩一定要经的起谎言,爱的起敷衍,忍的了欺骗,忘得了诺言,放的下一切,最后用笑来伪装你的泪眼!

天猫网友:染尘 /9 Demon。
评论:在混乱中成长;在成长中乱混。

腾讯网友:Paranoid. 偏执
评论:命是爸妈给的,珍惜点;路是自己走的,小心点。

网易网友:碎梦 3/3dream°
评论:婚外情可以是个浪漫的故事,但离婚则是一次惨痛的事故。

猫扑网友:惜一丝清冷
评论:人生没有彩排,每天都是直播;不仅收视率低,而且工资不高。

其它网友:Rainy°伤情
评论:世界上最动听的话不是我爱你,而是你的肿瘤是良性的!

搜狐网友:疲惫了放手了
评论:最郁闷的是:网上购票,钱从账户划去了,票没出来。

凤凰网友:若凌° Provence -
评论:何为女流氓?答曰:思想上的女流氓。生活上的好姑娘。外形上的柔情少女。心理上的变形金刚……

天涯网友:自戀的病源
评论:现在每天吃的是草,可是挤出来的却是青春痘。

百度网友:▲ 难分 2amor〃
评论:钱多钱少,够吃就好。人丑人美,顺眼就好。人老人少,健康就好。家穷家富,和气就好。

网站介绍 | 广告刊例 | 联系我们 | 版权声明 | 网站导航

品牌资讯网版权所有 未经允许 请勿复制或镜像 Copyright © 2012-2017 http://news.ppzixunw.com/, All rights reserved.